What changed
$RTX — Designs and manufactures aerospace and defense systems.
🎯 Q1 FY26 | Rev $22B | EPS $1.78 vs $1.52 🟢 | Margin 12.9%
💡 Consensus expected Q1'26 adjusted EPS of $1.52, but RTX delivered $1.78 (+17% beat). The market is still pricing RTX as a slow-growth defense conglomerate, but the 9% revenue growth (10% organic) and 21% EPS growth show a structural acceleration driven by commercial aerospace recovery and defense backlog conversion.
🏢 Business Quality: 8/10 | Valuation: fair
📉 Reward/Risk: Upside 15% to $208 (22x FY2026 EPS of $6.00) vs downside 10% to $163 (18x FY2026 EPS of $5.50). Ratio 1.5:1.
🔮 Catalyst: Upward guidance revision at next earnings (late July 2026). Metric: FY2026 adjusted EPS guidance raised from ~$5.80 to $6.00+. Failure signal: management maintains or cuts guidance despite Q1 beat, indicating one-time factors.
Also in play: $LMT $NOC $GD $BA $HII $TXT